10x Genomics stockholders re-elect Sri Kosaraju and Shehnaaz Suliman as Class III directors

10x Genomics, Inc.

Kosaraju received 189,313,724 votes for and 7,243,542 against; Suliman 168,973,468 for and 27,595,026 against.
Ratification of Ernst & Young as independent auditor for FY2025 passed with 215,766,816 votes for.
Non-binding advisory vote on named executive officer compensation approved with 164,321,765 votes for.
108,937,350 shares present or represented by proxy, representing 87.7% of eligible votes, constituting a quorum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.